| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.19B | -4.0% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.13B | — |
| Net income | ¥-0.13B | — |
| Gross margin | 6.9% | Net margin -67.5% |
| Revenue Q/Q | -34.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.18B | 93.1% |
| R&D | ¥0.00B | 0.7% |
| SG&A | ¥0.05B | 25.9% |
| Tax & other | ¥0.00B | 1.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
*ST纳川 ・ 翰宇药业 ・ 高盟新材 ・ 海伦哲 ・ 聚光科技 ・ 舒泰神 ・ *ST天喻 ・ 理邦仪器 ・ 欣旺达 ・ 行云科技 ・ 森远股份 ・ *ST亿通
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies